Vanguard Group Inc 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Voyager Therapeutics, Inc. VYGR | Vanguard Group Inc | 2,529,668 5.750% | 574,496 (+29.38%) | Filing |
| 2023-02-09 11:37 am Sale | 2022-12-30 | 13G | Voyager Therapeutics, Inc. VYGR | Vanguard Group Inc | 1,955,172 5.060% | -116,873 (-5.64%) | Filing |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Vanguard Group Inc | 2,072,045 5.460% | -345,606 (-14.30%) | Filing |
| 2021-02-10 12:00 pm Purchase | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Vanguard Group Inc | 2,417,651 6.450% | 324,603 (+15.51%) | Filing |
| 2020-02-11 4:44 pm Purchase | 2019-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Vanguard Group Inc | 2,093,048 5.640% | 2,093,048 (New Position) | Filing |